Form 10-K PharMerica CORP For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pharmerica (PMC) Tops Q4 EPS by 4c; Guides FY16 EPS Below Expectations
February 26, 2016 8:06 AM ESTPharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $520.6 million versus the consensus estimate of $506.4 million.
GUIDANCE:
Pharmerica sees FY2016 EPS of $1.95-$2.05, versus the consensus of $2.31. Pharmerica sees FY2016... More
